O'Brien Greene & Co. Inc Medpace Holdings, Inc. Transaction History
O'Brien Greene & Co. Inc
- $291 Million
- Q4 2024
A detailed history of O'Brien Greene & Co. Inc transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, O'Brien Greene & Co. Inc holds 12,837 shares of MEDP stock, worth $4.41 Million. This represents 1.46% of its overall portfolio holdings.
Number of Shares
12,837Holding current value
$4.41 Million% of portfolio
1.46%Shares
1 transactions
Others Institutions Holding MEDP
# of Institutions
622Shares Held
25MCall Options Held
42.8KPut Options Held
207K-
Black Rock Inc. New York, NY2.58MShares$885 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.55MShares$874 Million0.02% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT909KShares$312 Million1.51% of portfolio
-
State Street Corp Boston, MA753KShares$259 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA628KShares$216 Million0.02% of portfolio
About Medpace Holdings, Inc.
- Ticker MEDP
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 31,099,900
- Market Cap $10.7B
- Description
- Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...